Condition: Obesity Type 2 Diabetes Mellitus · Sponsor: Chinese University of Hong Kong
This study is designed to evaluate the efficacy, safety, and mechanisms of combining ESG and pulsENDO procedure in obese patients with T2DM
This description comes directly from the study's public registry record.
Stephen Ng · +85235052956 · stephenng@surgery.cuhk.edu.hk
Ivy Study coordinator · +85235052956 · ivypoon@surgery.cuhk.edu.hk
Always discuss trial participation with your own doctor first.
| Prince of Wales Hospital, the Chinese University of Hong Kong | Shatin, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07660445